InvestorsHub Logo
Followers 67
Posts 1300
Boards Moderated 0
Alias Born 08/12/2014

Re: None

Monday, 10/19/2020 10:02:46 AM

Monday, October 19, 2020 10:02:46 AM

Post# of 708088
Bye bye old timers and welcome again new comers!

It's a new world, new environment, and new dynamic for NWBO shareholders

We have had the journal article reporting blended and blinded trial data, which show promising and unprecedented results in some areas, and in general a worthy of approval data for GBM patients;

The subsequent update show data continued mature and got better and better;

then, FDA published "Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products Draft Guidance for Industry December 2019" https://www.fda.gov/regulatory-information/search-fda-guidance-documents/demonstrating-substantial-evidence-effectiveness-human-drug-and-biological-products, and NWBO adapted new endpoints in accordance with the new FDA guideline.

No one can get more clearer about the huge success of NWBO as of now, not only in GBM indication, but many, many beyond in the future

Now the market has to and has responded, and it's just beginning!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News